Show simple item record

dc.contributor.authorDoshi, Peter
dc.date.accessioned2017-05-25T01:16:27Z
dc.date.available2017-05-25T01:16:27Z
dc.date.issued2013-05-16
dc.identifier.citationDoshi, P. (2013). Influenza: marketing vaccine by marketing disease. BMJ 2013;346:f3037. DOI: https://doi.org/10.1136/bmj.f3037en_US
dc.identifier.urihttp://hdl.handle.net/10713/6608
dc.descriptionThe CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so.en_US
dc.description.urihttp://bmj.com/cgi/content/full/bmj.f3037?ijkey=VG6zCuSnIXsFDaT&keytype=ref
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subject.lcshCenters for Disease Control and Prevention (U.S.)en_US
dc.subject.meshVaccination--trendsen_US
dc.subject.meshInfluenza Vaccinesen_US
dc.subject.meshInfluenza, Human--epidemiologyen_US
dc.subject.meshInfluenza, Human--prevention & controlen_US
dc.titleInfluenza: marketing vaccine by marketing diseaseen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.f3037
dc.identifier.pmid23682040
dc.identifier.ispublishedNoen_US
dc.description.urinameClick here for the free full-text article on publisher’s websiteen_US
refterms.dateFOA2019-02-19T18:16:00Z


Files in this item

Thumbnail
Name:
Doshi_BMJ_Influenza_Marketing_ ...
Size:
326.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record